ArticleMaterials today. Bio2025

Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma.

Fan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.